Related Experiment Video
Updated: Jul 9, 2025

Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique
Published on: September 23, 2022
COVID-19 vaccine safety and side effects in children aged 5-11 years: a cross-sectional study
M A Nurhani1, H M S Farah1, N M A Ili1
1Hospital Tuanku Ja'afar, Jalan Rasah, Seremban, Negeri Sembilan, Ministry of Health Malaysia.
Insights
The Pfizer-BioNTech COVID-19 vaccine showed good tolerability in children, with most side effects being mild and short-lived. This supports vaccine safety for pediatric populations, including those with co-morbidities.
Area of Science:
- Pediatric Infectious Diseases
- Vaccinology
- Public Health
Background:
- The COVID-19 pandemic necessitated rapid vaccine development and deployment, including for pediatric populations.
- Assessing the safety and tolerability of vaccines in children is critical for public trust and informed decision-making.
- The Pfizer-BioNTech (BNT162b2) vaccine is a key tool in global vaccination efforts.
Purpose of the Study:
- To evaluate the safety and side effect profile of the Pfizer-BioNTech (BNT162b2) vaccine in children.
- To determine the proportion of children experiencing postvaccination side effects.
- To identify factors associated with the occurrence of side effects in pediatric vaccine recipients.
Main Methods:
- A cross-sectional study design was employed.
- Data were collected from 195 children vaccinated between February 3 and May 8, 2022.
- Parent or legal guardian completed self-administered questionnaires regarding side effects.
Main Results:
- 31.8% of vaccinated children reported side effects, most commonly injection site pain (29.7%), fever (15.9%), and localized inflammation (10.8%).
- No severe adverse events like anaphylaxis or myocarditis were reported.
- Children with underlying co-morbidities showed a higher proportion of side effects; no significant differences were noted based on age, weight, allergies, or premedication.
Conclusions:
- The BNT162b2 vaccine demonstrated good tolerability in the pediatric population studied.
- Reported side effects were predominantly mild and self-limiting.
- Findings support the safety of COVID-19 vaccination in children and inform healthcare providers, parents, and policymakers, particularly for high-risk groups.
Introduction:
The COVID-19 pandemic has prompted a global drive for vaccination, including children. Despite the urgency, understanding the safety and side effects remains crucial. Our study aimed to evaluate the safety of the Pfizer- BioNTech (BNT162b2) vaccine in children by determining the proportion of vaccinated children who experienced side effects and identifying factors associated with postvaccination side effects.
Materials And Methods:
A cross-sectional study was conducted among children who received the COVID-19 vaccine between 3 February and 8 May 2022. Data were collected using a self-administered questionnaire filled out by the parent or legal guardian.
Results:
The mean age of the study participants was 9 years old and 43.1% were males. Out of the 195 participants in the study, 62 (31.8%) reported side effects after vaccination. The most frequently reported side effects were pain at the injection site (29.7%, n=58), fever (15.9%, n=31), localised inflammation (10.8%, n=21) and arthralgia/myalgia (9.2%, n=18). There were no reported severe adverse events such as anaphylaxis or myocarditis. Most side effects occurred within the first two days post-vaccination. There was a higher proportion of side effects among children with underlying co-morbidities. No significant differences were observed based on age, weight, ethnicity and the presence of allergies, or the use of premedication.
Conclusion:
The BNT162b2 vaccine was generally welltolerated in children, with most side effects being mild and self-limiting. These findings support the safety of the COVID-19 vaccine and would guide healthcare professionals, parents and policy-makers in making informed decisions about COVID-19 vaccination, especially among high-risk groups.
More Related Videos
13:36Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
Published on: May 6, 2015
12:09Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection
Published on: May 2, 2011
Related Concept Videos
Vaccinations
Teratogenicity
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Local Anesthetics: Adverse Effects
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Allergic Drug Reactions